Document Detail

A case of anaphylaxis to Pollinex® Quattro MPL-4.
MedLine Citation:
PMID:  24702876     Owner:  NLM     Status:  In-Data-Review    
We described the first case reported in literature of anaphylactic shock after administration of pollen extract vaccine chemically modified (allergoid) adsorbed onto L-Tyrosine depot adjuvanted with monophosphoryl lipid A (Pollinex® Quattro MPL-4).
L Borgonovo; S Piconi; A Fusi; E Iemoli
Related Documents :
6864016 - An autopsy study of 306 cases of maternal death in japan.
24702876 - A case of anaphylaxis to pollinex® quattro mpl-4.
8116586 - Restraint asphyxiation in excited delirium.
19767406 - Anticoagulation strategies for venous thromboembolism.
2065616 - Pediatric congenital nasal masses.
16876776 - The osler slide, a demonstration of phagocytosis from 1876 reports of phagocytosis befo...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European annals of allergy and clinical immunology     Volume:  46     ISSN:  1764-1489     ISO Abbreviation:  Eur Ann Allergy Clin Immunol     Publication Date:  2014 Jan 
Date Detail:
Created Date:  2014-04-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101466614     Medline TA:  Eur Ann Allergy Clin Immunol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  46-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Exclusively breastfed infants at risk for false negative double blind placebo controlled milk challe...
Next Document:  Skin prick test: the only predictive tool of anaphylaxis? A case report.